Vanda Pharmaceuticals (VNDA) Q4 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.19
-0.11
-0.03
0.05

Details

Expected EPS
-0.156667
Actual EPS
-0.09
Surprise EPS
0.07
Surprise Percent
+42.55%

Description

Vanda Pharmaceuticals (VNDA) has reported earnings of -0.09 per share for Q4 2024.

0 Comments

Share your thoughts